Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atezolizumab in urothelial bladder carcinoma.
Hamilou Z, Lavaud P, Loriot Y. Hamilou Z, et al. Among authors: lavaud p. Future Oncol. 2018 Feb;14(4):331-341. doi: 10.2217/fon-2017-0433. Epub 2017 Nov 14. Future Oncol. 2018. PMID: 29135284 Review.
Durvalumab in urothelial cancers.
Lavaud P, Hamilou Z, Loriot Y, Massard C. Lavaud P, et al. Expert Rev Anticancer Ther. 2018 Apr;18(4):311-318. doi: 10.1080/14737140.2018.1443812. Epub 2018 Mar 5. Expert Rev Anticancer Ther. 2018. PMID: 29486607 Review.
Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen.
Gravis G, Billon E, Baldini C, Massard C, Hilgers W, Delva R, Walz J, Pignot G, Rybikowski S, Dermeche S, Thomassin J, Brunelle S, Lavaud P, Loriot Y; French Genito-Urinary Tumor Group (GETUG). Gravis G, et al. Among authors: lavaud p. Eur J Cancer. 2018 Nov;104:236-238. doi: 10.1016/j.ejca.2018.09.002. Epub 2018 Oct 11. Eur J Cancer. 2018. PMID: 30316610 No abstract available.
Clinical outcome after progressing to frontline and second-line Anti-PD-1/PD-L1 in advanced urothelial cancer.
Gómez de Liaño Lista A, van Dijk N, de Velasco Oria de Rueda G, Necchi A, Lavaud P, Morales-Barrera R, Alonso Gordoa T, Maroto P, Ravaud A, Durán I, Szabados B, Castellano D, Giannatempo P, Loriot Y, Carles J, Anguera Palacios G, Lefort F, Raggi D, Gross Goupil M, Powles T, Van der Heijden MS. Gómez de Liaño Lista A, et al. Among authors: lavaud p. Eur Urol. 2020 Feb;77(2):269-276. doi: 10.1016/j.eururo.2019.10.004. Epub 2019 Nov 5. Eur Urol. 2020. PMID: 31699525
Studying Rarity in Bladder Cancer.
Thibault C, Lavaud P, Loriot Y. Thibault C, et al. Among authors: lavaud p. Eur Urol. 2020 Apr;77(4):447-448. doi: 10.1016/j.eururo.2019.11.018. Epub 2019 Dec 5. Eur Urol. 2020. PMID: 31812317 No abstract available.
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group.
Sroussi M, Elaidi R, Fléchon A, Lorcet M, Borchiellini D, Tardy MP, Gravis G, Guérin M, Laguerre B, Estrade F, Delva R, Barthélémy P, Loriot Y, Lavaud P, Lebret T, Neuzillet Y, Penel N, Houede N, Pouessel D, Rousseau B, Mussat E, Gross-Goupil M, Culine S, Gauthier H, Gobert A, Roupret M, Huillard O, Tartas S, Radulescu C, Allory Y, Oudard S. Sroussi M, et al. Among authors: lavaud p. Clin Genitourin Cancer. 2020 Aug;18(4):295-303.e3. doi: 10.1016/j.clgc.2019.11.014. Epub 2019 Dec 5. Clin Genitourin Cancer. 2020. PMID: 31882335
Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial.
Dumont C, Baciarello G, Bosset PO, Lavaud P, Colomba E, Massard C, Loriot Y, Albiges L, Blanchard P, Bossi A, Nenan S, Fizazi K. Dumont C, et al. Among authors: lavaud p. Clin Genitourin Cancer. 2020 Dec;18(6):444-451. doi: 10.1016/j.clgc.2020.03.017. Epub 2020 Apr 7. Clin Genitourin Cancer. 2020. PMID: 32349927 Clinical Trial.
89 results